text:
MATCH REPORT: AUSTRALIA V SAMOA
James Coman Rugby League World Cup 2017 Reporter
Sat 18 Nov 2017, 01:48 AM
Valentine Holmes has become the first player in World Cup history to record five tries in a single match as the electrifying winger inspired Australia to a resounding 46-0 victory at Darwin Stadium.
In steaming hot conditions at Darwin Stadium, Holmes scored two tries in the first half before running in another three in the second, to cap off a record-breaking match which saw Australia notch-up their 10th straight World Cup victory.
Australian fullback Billy Slater, retook his place alongside Jarryd Hayne for most tries in World Cup history after his four-pointer in the opening half. While Melbourne Storm teammate Cameron Smith, equaled Bob Fulton's record of 15 World Cup appearances in the green and gold jersey.
As Samoa kicked off to start the first ever game of international Rugby League in Darwin, the howling wind slowed down to a slight breeze making the hot conditions even hotter for the players.
In the eighth minute of the match, compound errors from Samoa gifted Australia easy passage down the field for Cooper Cronk to put up a short chip over the defence for Australia's first try of the match.
Dugan outleaped his opposition to tap the ball back for Holmes who superbly plucked the ball off his shoestrings to score Australia's first points of the game.
Following the try, Australia started to find their rhythm as things started to look dire for Samoa.
And just eight minutes later, Holmes got his second of the night after linking with Cooper Cronk for a scintillating coast-to-coast effort.
Picking the ball up on his own try line, Holmes blitzed Samoa's defence running 20 metres upfield before unloading to Cooper Cronk who quickly returned the favour to put Holmes in open pasture, running the remaining 50 metres to score against the run of play.
With the scores now at 12-0, Australia really started to apply the heat to the Samoan side as they ran in another three tries in the first half.
The final 10 minutes of the half were highlighted by a double from five-eighth, Michael Morgan, who took advantage of some tired defenders late in the half to stretch their lead to 30 before the break.
As the players returned for the second hald, Samoa came out on the offensive as they tried to bash their way back into the match.
In the 51st minute, Holmes dampened the spirits of Samoa and recorded his third try of the match to complete his hat-trick.
Unfortunately for Samoa, three wasn't enough for the prolific try scorer who ran in another two tries in the second half to become the first player in World Cup history to record five tries in a single match.
With six minutes left to play, Samoa's goal-line drop-out ended up in the hands of Canterbury-Bankstown Bulldogs big man, David Klemmer.
Klemmer took on the Samoan line before drawing and passing to Holmes who's blistering speed and agility was too much, carving his way through a maze of Samoan defenders before crossing over the in-goal to complete a historic five-try haul.
Australia finished the match with eight tries and eight conversions to finish victors 46-0.
The loss means Samoa is sent home from the World Cup while Australia will prepare to play the winner of New Zealand and Fiji on Saturday.
Adam Reynolds Menulog Team of the Decade - Halfback
Presented By Menulog 4 days ago


text:
/*
 * To change this license header, choose License Headers in Project Properties.
 * To change this template file, choose Tools | Templates
 * and open the template in the editor.
 */
package arbor.view;

import arbor.util.ArborVector;

/**
 *
 * @author Alexander Ramsay-Baggs
 */
public class Camera {

    public static Camera main = new Camera();

    private Camera() {
    };

    private ArborVector position = new ArborVector();
    private float scale = 1f;

    public ArborVector getPosition(){
        return position;
    }

    public void setPosition(ArborVector newPosition) {
        position = newPosition;
    }

    public void translate(ArborVector translate) {
        position.x += translate.x;
        position.y += translate.y;
    }

    public void setScale(float newScale) {
        scale = newScale;
    }

    public void shiftScale(float scaleShift) {
        scale += scaleShift;
    }

    public float getScale() {
        return scale;
    }
}

redpajama_set_name: RedPajamaGithub


A whole bunch of other stuff we probably haven't even considered yet!
If you'd like to contribute a guest post then take a look at the Write For Us page and check the criteria/guidelines before getting in touch.
If you have any suggestions of content we can publish then let us know.


text:
Roger Goodell Gave Himself a $30 Million Pat on the Back in 2011, Nearly Tripling His Salary as NFL Commissioner
by Luke Hughes on Fri, Feb 15, 2013 at 5:33PM
The NFL is a multi-billion dollar business, which both teams and players divvy up yearly. But don't worry, commissioner Roger Goodell isn't missing his chance to cash out.
After making an average of about $10 million over the first five years as commissioner, Goodell saw it fit for a hefty increase in 2011, according to Sports Business Daily. Goodell tripled his salary in 2011, as he took home close to $30 million for the year.
Goodell's salary was almost $10 million higher than any NFL player in 2011 and, as a matter of fact, higher than any single salary ever in the history of the league. What's more, Goodell's increase came after months of lobbying to lower player salaries in the most recent collective bargaining agreement.
It's not crazy to think that Goodell deserves to be paid well, especially after locking down a new CBA with the Players Union, avoiding an extended lockout — into the season, that is — and securing some very lucrative new television contracts.
Goodell deserves to be paid well just like any other successful CEO, which is essentially his role within the NFL. But the sheer growth of his salary in such a small window of time is the real eyebrow raiser. Not to say that it's right or wrong, just that it is conspicuous.
Have a question for Luke Hughes? Send it to him via Twitter at @LukeFHughes or send it to his Mailbag.
Chip Kelly Already Has His Quarterbacks, So Trading Nick Foles Should Be No Brainer for Eagles

redpajama_set_name: RedPajamaCommonCrawl


text:
AirGuide Business
Aerospace & Defense News - Defense Africa / Middle East.
New York, Geneva (AirGuideBusiness - Aerospace & Defense News - Defense Africa / Middle East) Oct 17, 2010
Israel Aerospace Industries Oboronprom and Israel Aerospace Industries have signed an agreement which clears the way for the production of Israeli-designed unmanned air vehicles in Russia. Signed in Israel on 12 October, the partnership will lead to the delivery of "UAV assembly elements and services" to the Russian company, IAI says. "The deal
will begin to be implemented during 2011," it adds. Oct 15, 2010
Israel Aerospace Industries Israel Aerospace Industries is looking for a foreign partner to invest in the full development of its Panther/K-80 tiltrotor unmanned air vehicle. The companyOs search for an outside investor follows the refusal of the Israeli defence ministry of its request to extend the deadline to receive tenders for a brigade-level UAV. IAI had requested more time to complete the development of its new tiltrotor, with responses having been due by 20 September. The Panther uses an innovative automatic flight-control system to control the transitions between its hovering take-off phase and forward flight, and back before landing. Oct 14, 2010
Pratt & Whitney, General Electric An announced engine selection for Israel's first batch of F-35 Joint Strike Fighters has...


Last October, my husband and I set off "to see what we could see". We had never spent much time in north Alabama, but it was a day's drive away and far enough north to support different plant communities than Florida. In anticipation, we poured through magazines, websites and joined the Alabama Wildflower Society (AWS), the Alabama equivalent of our Florida Native Plant Society.
Then we found Linda. Actually, I think, Linda found us; two lost souls wandering through the Alabama Wildflower Society website. You see, Linda has been involved in the AWS for quite some time and she was thrilled to hear that some of the Florida members are interested in her state. We became fast friends, just over the phone. But that's the south, where everyone is "Darlin" and no one is a stranger even if you just met, especially if you are another native plant lover. The world does not know more welcoming people than native plant people!
When we arrived in Birmingham, Linda was waiting for us, along with about 20 other local native plant enthusiasts. You see, she had already contacted the native plant members in her area and they were ready and eager to showcase their state.
Marty Shulman, the retired Land Manager of Ruffner Mountain Nature Preserve, explained how Birmingham became one of the top steel producing regions in the country, first utilizing Longleaf Pines for the process, then moving on to coal, just as the pines were nearly depleted. Iron ore, coal and limestone are the three ingredients needed to make steel and central Alabama has all three. Thus, explains the 56-foot-tall cast iron statue of Vulcan, the Roman God of fire and forge, in the center of Birmingham.
Charles Yeager, Manager of Turkey Creek Preserve, in the heart of the Birmingham, explained how this inter-city preserve had been abandoned by all and utilized by gangs who drove their cars into the river to wash them. When the land was at its bleakest point, the city proposed building a prison on the site. But to the local residents, this was the last straw. They rose up, banded together and demanded the city preserve it. Today, it is a beautiful urban renewal project, much loved and used by the local residents.
While visiting the Birmingham Botanical Gardens we met John Manion, Curator of the Kaul Wildflower Garden, a 17-acre garden within the main Garden. John is the charming personality who created the native plant studies program at the Gardens. He also manages one of the world's rarest plants, the Tutwiler's spleenwort, Asplenium tutwilerae, a fern so rare that less than 5 acres of land hold the only known population in the world.
As we ventured north from Birmingham, the terrain became more rugged, sporting steep canyons with gorges sliced by rivers and streams.
Linda set up a meeting with more locals, like Jim and Fay Lacefield, two school teachers who saved their own salaries and bit-by-bit bought up 700 acres of canyon land with coursing streams, then, gave it away! In perpetuity, Cane Creek Canyon Preserve will remain a wilderness area protected by The Nature Conservancy, thanks to two people who had the love and foresight to preserve it.
On to Huntsville where the US Space and Rocket Center is located, the sister facility to Cape Canaveral, and Wheeler Wildlife Refuge, a 37,000 acre preserve for migrating birds, established by FD Roosevelt. Just to the east is Scottsboro and underground is one of the most beautiful caverns in the United States. Cathedral Caverns State Park has some of the largest chambers in a cave system that I've ever seen. One stalagmite is the size of a school bus and bears witness to the earthquakes the region has recently endured.
As we fanned over to the northeast corner of the state we crossed a national preserve, part of the US National Park System. Cousin to our western parks, and equally impressive, the Little River Canyon National Preserve sports a river flowing atop a mountain. The steep canyon walls, appropriately named "Little River", are the most extensive canyon and gorge system in the eastern United States, and habitat for the carnivorous green pitcher plant and Kral's water plantains.


Among the musicians celebrating our songs on their latest albums are: jazz vocalist Kevin Mahagony with the title track of MY ROMANCE (Warner Bros.)...Helen Reddy covering ""You're Just in Love"" and ""Love, Look Away"" (CENTER STAGE; Varse Sarabande)...Bette Midler rockin' with ""One Monkey Don't Stop No Show"" (BATHHOUSE BETTY; Warner Bros)... Julio Iglesias with ""Can't Help Falling in Love"" (MY LIFE: THE GREATEST HITS; Sony)...Vanilla Fudge doing a take on ""Hound Dog"" (THE BEAT GOES ON; Sundazed Music)...Ron Raines with ""It's a Grand Night for Singing,"" ""Oh, What a Beautiful Mornin',"" ""My Defenses are Down,"" ""Soliloquy"" and ""This Nearly Was Mine"" on BROADWAY PASSION (JAY)...Anne Kerry Ford giving equal time to Oscar Hammerstein II and his protg, Stephen Sondheim, on SOMETHING WONDERFUL (LML Music)...Sisters Kate and Anna McGarrigle pairing on ""What'll I Do?"" (THE McGARRIGLE HOUR; Hannibal)...and the inseparable Alice Ripley and Emily Skinner, featuring ""If We Never Meet Again"" from RAGS and Irving Berlin's ""Sisters"" on their debut duo album, DUETS (Varse Sarabande).
From left to right: Joshua Logan, Irving Berlin, Richard Rodgers, Oscar Hammerstein II, Dorothy Fields, Herbert Fields and seated, Ray Middleton and Ethel Merman, 1946.


text:
Felix Shepherd
Sounds like — James Bay,Vampire Weekend, Catfish And The Bottlemen
Location — Birmingham
Credit: Felix Shepherd
Follow Felix Shepherd
Felix Shepherd is a driven artist with a passion for dreamy, cinematic indie-pop melodies.
Hailing from Birmingham UK, the 19-year-old singer-songwriter has developed a sound that has fused the likes of James Bay, Matt Corby and Vampire Weekend. The earnest intimacy of his melodies complement the far-reaching textures and ambient soundscapes of his tracks, going for a diverse and personal sound.
Felix Shepherd began his career at the age of 13 playing small gigs and open mic nights around the local bars. Supported greatly by his mother who bought him his first guitar at the young age of 7. The singer-songwriter grabbed the attention of BBC Introducing with his atmospheric sounds in 2016, things we're really looking up for this young teen....
However, in July 2016, his dream was put on hold when Felix took a hiatus from making music after being diagnosed with anorexia, being taking seriously ill he removed himself from all social media and the eye of the public. It was a long road to recovery from there, it took serious character and mental determination for him to beat this but nevertheless he decided to focused on aspects of his personal life where he decided he was transgender, it took a while for him to build up the confidence to return to his career, he know it meant he had to start again being unsure of peoples reactions and support he returned in 2017 writing and producing the material for the EP being released this year.
Now with the support of a loyal fan base, family and friends, Felix is set to release his debut EP 'Polar Points' on April 6th and is celebrating the release with an EP Launch at The Sunflower Lounge on the 7th April 7:30 pm.
The Single from the EP 'Always Been' recently had it's exclusive play on BBC Introducing with the release date set 2nd March.
He has plans to keep releasing new music after this EP and get out and play some shows, he also makes regular appearances on the Birmingham circuit play gigs for the likes of Birmingham Promoters.
Felix Shepherd Tracks
Felix Shepherd Photos
Felix Shepherd's Next Gig
Date Saturday 7 April 2018 at 18:23
Address The Sunflower Lounge, Smallbrook Queensway, Birmingham, UK, B5 4EG
Felix Shepherd's Merch
The Rezner
Ivory Wave


Housing affordability issues are affecting large parts of the population. So it's no surprise that there is substantial interest in where the most and least affordable places to live are, for citizens and policymakers alike.
The ONS recently published some analysis on housing affordability, which uses 2016 house price data and 2013 / 2014 household income data. Inspired by ONS analysis, and the availability of more recent small area weekly income data, we have constructed a series of datasets (8 in total) around the relative affordability of buying a house in any given area. All of which are available in our Local Insight and Community Insight tools.
Our housing affordability indicators have been added to more than 700 other neighbourhood level datasets, already preloaded into Local Insight.
Local Insight provides up-to-date local level data, matched to the communities that you care about; whether that is wards, GP localities or school catchment areas.
And gives you instant access to neighbourhood level data, visualised on maps, dashboards and in reports.
Map from Local Insight: Savings required for 15% mortgage deposit and stamp duty for an average priced property.
gain insight to help monitor and develop your housing policies.
We have produced four measures around housing affordability for average house prices at output area (OA) level through combining data from Land Registry Price Paid Data from December 2015 to November 2016 with small area estimated weekly income data from the ONS.
This gives a much finer level of granularity than data directly available from ONS on housing affordability in local areas. Data at this level can give insights into local differences and housing inequalities at very small level, such as neighbouring streets for example.
However, given that these are very small areas, this data may contain some anomalies, due to the very low number of sales in some areas (which is why multiple months worth of transaction data was included). This could potentially mean that the data is more prone to being distorted by expensive pockets of housing if it contains them, and may not be representative of the local area as a whole.
We have also produced housing affordability indicators for entry level properties. These give a useful insight to the local picture for first time buyers, and can contribute to the overall picture of sustainable and good growth in a local area.
Creating these indicators using underlying OA level data for the whole country, would be very tricky as it relies upon at least 4 entry level properties being sold within each output area. Instead for these indicators, we have used MSOA level Land Registry Price Paid data as the underlying data.
For each of the indicators outlined below, we have produced datasets both for average house prices and entry level house prices (defined as house prices in the lower quartile for a particular local area) for England.
Affordability gap: This is the difference between the average house price and 4.5 times the average annual salary. The higher the amount, the more unaffordable housing is in that area. The figure 4.5 is used as this is typically the amount that mortgage providers are prepared to lend.
Estimated savings required: This is an estimate of the upfront costs to take out a mortgage on a house in the area, based only on area house prices. It represents a 15% deposit (assumed as a typical amount) on the total value of the house and stamp duty.
Required savings to salary ratio: A very rough estimate (it does not take any living or other costs into account) of the number of months one would have to save an average salary to afford to take out a mortgage in the area.
Total price to annual income ratio: A very rough estimate (again, no other costs are taken into account) of the number of years it would take for someone on an average salary to afford to buy a house in their area outright.
We'll be putting another post together shortly on some of the headline stories we picked out from the data – keep your eyes peeled!
We would also love to know the local stories you find for the areas you work in. To explore this data (and a whole heap more!), sign up for a free trial of Local Insight.


text:
General Mills cuts its profit forecast as freight and commodity costs weigh
Published Wed, Mar 21 20188:20 AM EDT Updated Wed, Mar 21 20188:50 AM EDT
Cheerios cereal maker General Mills cut its yearly earnings forecast.
The company cited a sharp increase in freight and commodity costs.
General Mills shares sank 6 percent in premarket trading on the news.
Cheerios cereal maker General Mills cut its full-year earnings forecast due to a sharp increase in freight and commodity costs, driving its shares down 9 percent in premarket trading on Wednesday.
The Minneapolis-based company, which owns the Häagen-Dazs and Betty Crocker brands, said it would try to strengthen next year's earnings by improving its distribution network, cutting costs globally and finding ways to eke out better product margins.
General Mills, like other U.S. packaged food companies, has been facing higher transportation costs as railroads and truck fleets have raised prices amid a shortage of drivers, reduced capacity, higher fuel prices and a strengthening U.S. economy.
"Like the broader industry, we're seeing sharp increases in input costs, including inflation in freight and commodities," General Mills Chief Executive Jeff Harmening said in a statement.
Harmening said he was disappointed with third-quarter operating profit and that General Mills was moving urgently to reduce costs, hoping to minimize damage to full-year earnings.
Cost-saving measures include increasing the number of qualified freight carriers, using different modes of transportation and tightly monitoring spending for the rest of the fiscal year, General Mills said.
Cost savings might only be a temporary fix and run out of steam as top-line weakness trickles through, Bernstein analyst Alexia Howard wrote in a note. Howard said she was uncertain that General Mills would be able to pass on higher costs and freight inflation to struggling retailers that are fighting to cut costs themselves.
General Mills, which also makes Yoplait yogurt and Nature Valley granola bars, now expects fiscal 2018 adjusted earnings per share to grow up to 1 percent, compared with a prior forecast for a 3 percent to 4 percent increase.
Net income attributable to General Mills more than doubled to $941.4 million in the third quarter ended Feb. 25, helped by a one-time tax benefit of $504 million from changes in the U.S. tax code.
Excluding one-time items, the company earned 79 cents per share.
Net sales rose 2.3 percent to $3.88 billion.
Analysts had expected third-quarter earnings of 78 cents per share and revenue of $3.78 billion, according to Thomson Reuters I/B/E/S.
General Mills Inc


After a much needed Easter break, House members return to Columbia this week. As May 1st looms (crossover date), members will be pushing for their bills to pass either the House or the Senate by then if they hope for passage this year. For us, this means the next few weeks will be a whirlwind of legislative activity.
Senators returned last week to begin reviewing the House's budget and will continue those discussions this week in the Finance Committee. Senator Harvey Peeler unexpectedly resigned as Majority Leader last Tuesday citing a need to focus on a primary challenger in his district and a desire to share some leadership responsibilities in the Senate. The Republican Caucus met the next day and elected Senator Shane Massey as the new Majority Leader. Sen. Massey has been a supporter of conservation issues in the Senate and we look forward to working with him.
1. Banning lead wheel weights: A group of 10-12 year old students from the Charles Townes Center for gifted students are making an impact on the school's Lego robotics team nicknamed "The Hyperbolics." The theme of this year's Lego competition was Trash Trek and as their project the Hyperbolics took on the task of getting rid of lead-based wheel weights. Lead wheel weights can fall off, degrade, and travel in stormwater runoff threatening our waterways.
Students started off with a public awareness campaign, website and video. The Hyperbolics then got a meeting with the Greenville Legislative Delegation urging them to look at legislation. They also landed the support of the Automotive Maintenance and Repair Association, Motorist Assurance Program and Plombco, a major manufacturer of wheel weights, who put out endorsements and a press release supporting potential legislation.
On the final day before lawmakers left for Easter recess, Representative Bruce Bannister and the Greenville delegation introduced H.5141. Senator Ross Turner plans to introduce a companion bill in the Senate. Students are trying to drum up support in the House and Senate to get it passed before the session ends in June.
The bill is waiting for a subcommittee hearing in the House Commerce, Labor and Industry (LCI) Committee, but the crossover date is looming and we need to hustle. Can you help us by calling LCI members and asking them to push for a subcommittee hearing?
2. Immunity for Industry: Senators recently introduced a bill that would protect industry from nuisance claims. If S.1062 passes, no "existing industrial facility" can be sued for nuisance because of any "changed conditions" in the existing facility. This could include anything from increasing the size to a landfill changing the kind of "waste" it accepts (i.e. human sewage, coal ash, etc.). A "changed condition" could increase the odors, noise, dust, traffic, emissions, discharges, etc such that their neighbors' properties become uninhabitable.
This is an inexcusable attempt to obtain immunity for horrible nuisances, negatively impacting property values and the quality of life of their neighbors. This bill will be in Senate LCI Subcommittee on April 21st. Please help us by calling Senate LCI members.
3. Fight for the Auto Stay: In the last several years, we have had numerous conversations about the need to protect fair regulations that enable citizens, and in some cases, your constituents, to protect themselves from unlawful pollution. While we have fought back many of these rollbacks, two bills remain a threat this year. H.5090, was introduced last week and awaits review in House Judiciary. It is similar to S.165 which is currently stalled on the Senate calendar. Although described as being a 'business friendly' clean-up of language that allows 'frivolous' lawsuits to delay road projects, these bills would limit the ability of citizens to protect themselves from unwanted pollution. Read what we shared with House members.
4. Protecting Lake Conestee Nature Park: After about two years of pursuing recognition of Lake Conestee Nature Park as a "Wildlife Sanctuary" in state statutes (like Beidler Forest and numerous other properties around the state) our friends at the Conestee Foundation have H.4743, introduced by Representatives Eric Bedingfield and Chandra Dillard. After passing the House, this bill will be heard in Senate Fish Game and Forestry Subcommittee this Thursday. We will be there speaking in support.
5. Impacts from Mine Blasting: As many communities adjacent to mining operations can attest, we need stronger mining laws. We are grateful for Rep. Kennedy and numerous co-sponsors for supporting legislation to require minimum distances from communities when conducting blasting at mines. We will be joining Sierra Club and Sustainable Midlands in the House Ag Subcommittee Thursday to support H.4206.
6. Conservation Bank: We'd like to thank Senators on Senator Setzler's Finance Subcommittee for eliminating provisos intended to redirect funds from the Conservation Bank to DNR. We look forward to helping DNR find another source of funding and are hopeful that the full Senate Finance committee with fully fund the Bank this week.


text:
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Download "Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE"
Vivien Morton
1 Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) (401) FOR IMMEDIATE RELEASE CVS HEALTH REPORTS SECOND QUARTER RESULTS Second Quarter Year-over-year Highlights: Net revenues increased 4.5% to $45.7 billion GAAP diluted EPS from continuing operations of $1.07, including a $135 million, or 13 cents per share, goodwill impairment charge related to the RxCrossroads business Adjusted EPS of $1.33 Year-to-date Highlights: Generated cash flow from operations of $5.5 billion; free cash flow of $4.6 billion 2017 Guidance: Narrowed and revised full year GAAP diluted EPS from continuing operations to $4.92 to $5.02, including the goodwill impairment charge, from $5.02 to $5.18 Narrowed full year Adjusted EPS to $5.83 to $5.93 from $5.77 to $5.93 Provided third quarter GAAP diluted EPS from continuing operations of $1.20 to $1.23 Provided third quarter Adjusted EPS of $1.47 to $1.50, reflecting the timing of operating profit between the third and fourth quarters related to the Medicare Part D operations Confirmed full year cash flow from operations of $7.7 to $8.6 billion; free cash flow of $6.0 to $6.4 billion WOONSOCKET, RHODE ISLAND, August 8, CVS Health Corporation (NYSE: CVS) today announced operating results for the three and six months ended June 30, President and Chief Executive Officer Larry Merlo stated, The second quarter results we posted today keep us nicely on pace to achieve our full-year targets. Operating profit in the Retail/LTC Segment was in line with expectations while operating profit in the Pharmacy Services Segment exceeded expectations. At the same time, we have generated substantial free cash flow year-to-date and continued to return significant value to our shareholders through dividends and share repurchases. While we are pleased to report results consistent with our expectations, we won t be satisfied until the total enterprise returns to healthy levels of earnings growth. Mr. Merlo continued, Given our performance in the first half and our confidence in our expectations for the back half of this year, we are narrowing and raising the midpoint of our Adjusted EPS guidance for Additionally, our differentiated value proposition continues to resonate in the marketplace. The 2018 selling season is shaping up to be another successful one for our PBM, with solid gross and net new business achieved to date. Revenues Net revenues for the three months ended June 30, 2017 increased 4.5%, or $2.0 billion, to $45.7 billion, up from $43.7 billion in the three months ended June 30, Revenues in the Pharmacy Services Segment increased 9.5% to $32.3 billion in the three months ended June 30, This increase was primarily driven by growth in pharmacy network claim volume as well as brand inflation and specialty pharmacy volume, partially offset by increased generic dispensing and price compression. Pharmacy network claims processed during the three months ended June 30, 2017 increased 10.3% on a 30-day equivalent basis, to million, compared to million in the prior year. The increase in pharmacy network claim volume was primarily due to an increase in net new business. Mail choice claims processed during the three months ended June 30, 2017 increased 5.2%, on a 30-day equivalent basis, to 65.6 million, compared to 62.3 million in the prior year. The increase in the mail choice claim volume was primarily driven by continued adoption of our Maintenance Choice offerings and an increase in specialty pharmacy claims. 1
2 Revenues in the Retail/LTC Segment decreased 2.2% to $19.6 billion in the three months ended June 30, The decrease was largely driven by a 2.6% decrease in same store sales, an increase in the generic dispensing rate and continued reimbursement pressure. Pharmacy same store sales decreased 2.8% and were negatively impacted by approximately 410 basis points due to recent generic introductions. Same store prescription volumes remained flat, on a 30-day equivalent basis, in the three months ended June 30, The previously-announced restricted networks that exclude CVS Pharmacy had a negative impact of approximately 460 basis points on same store prescription volumes. Front store same store sales declined 2.1% in the three months ended June 30, The shift of the Easter holiday to the second quarter in 2017 from the first quarter in 2016 had an approximately 75 basis point positive impact. Front store same store sales were negatively impacted by softer customer traffic and efforts to rationalize promotional strategies, partially offset by an increase in basket size. For the three months ended June 30, 2017, the generic dispensing rate increased approximately 130 basis points to 87.2% in our Pharmacy Services Segment and increased approximately 150 basis points to 87.6% in our Retail/LTC Segment, compared to the prior year. Operating Profit Consolidated operating profit for the three months ended June 30, 2017, decreased $240 million, or 10.2%. The decrease was partially due to a goodwill impairment charge of $135 million related to the RxCrossroads reporting unit within the Retail/LTC Segment. Additionally, the previously-announced restricted networks that exclude CVS Pharmacy and continued reimbursement pressure in the Retail/LTC Segment negatively impacted operating profit. This was partially offset by growth in pharmacy network claim volume and growth in specialty pharmacy in the Pharmacy Services Segment and a $71 million decrease in acquisition-related integration costs in the three months ended June 30, 2017 versus the same quarter last year. Net Income and Earnings Per Share Net income for the three months ended June 30, 2017 increased $174 million or 18.8%, to $1.1 billion. The increase was primarily due to the absence of a $542 million loss on early extinguishment of debt in the current year, partially offset by the $240 million decrease in operating profit and an increase in the effective income tax rate, from 39.5% to 41.1%. The increase in the tax rate was primarily due to the nondeductible goodwill impairment charge of $135 million, or 280 basis points, partially offset by $14 million in discrete tax benefits related to the required adoption of new accounting guidance for share-based compensation on January 1, GAAP earnings per diluted share from continuing operations ( GAAP diluted EPS ) for the three months ended June 30, 2017 was $1.07, compared to $0.86 in the prior year. Adjusted earnings per share ( Adjusted EPS ) for the three months ended June 30, 2017 and 2016, was $1.33 and $1.32, respectively. Further detail is shown in the Adjusted Earnings Per Share reconciliation later in this release. 2
3 Guidance The Company narrowed and revised full year GAAP diluted EPS guidance to $4.92 to $5.02, including the goodwill impairment charge, from $5.02 to $5.18. The Company narrowed full year Adjusted EPS guidance to $5.83 to $5.93 from $5.77 to $5.93. In the third quarter, the Company expects to deliver GAAP diluted EPS of $1.20 to $1.23 and Adjusted EPS of $1.47 to $1.50 which are affected by the timing of the Medicare Part D operating profit between the third and fourth quarters relative to the prior year, resulting from the variability between the quarters as members move through the risk corridor. The third quarter GAAP diluted EPS guidance also includes an estimated loss on the previously-disclosed settlement of a defined benefit pension plan. The Company confirmed its 2017 cash flow from operations guidance of $7.7 to $8.6 billion and free cash flow guidance of $6.0 to $6.4 billion. These 2017 guidance estimates assume the completion of $5.0 billion in share repurchases. Real Estate Program During the three months ended June 30, 2017, the Company opened 27 new retail locations and closed three retail locations. In addition, the Company relocated 10 retail locations. As of June 30, 2017, the Company operated 9,700 retail locations, including pharmacies in Target stores, in 49 states, the District of Columbia, Puerto Rico and Brazil. As previously disclosed, the Company intends to close a total of approximately 70 retail stores during 2017 and expects to take a cumulative charge of approximately $220 million primarily associated with the remaining lease obligations of such stores. The Company closed 63 retail stores and took a charge of $205 million in the six months ended June 30, The Company expects to close approximately seven additional retail stores during the remainder of Teleconference and Webcast The Company will be holding a conference call today for the investment community at 8:30 am (EDT) to discuss its quarterly results. An audio webcast of the call will be broadcast simultaneously for all interested parties through the Investor Relations section of the CVS Health website at This webcast will be archived and available on the website for a one-year period following the conference call. About the Company CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at Forward-Looking Statements The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled Cautionary Statement Concerning Forward-Looking Statements in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Tables Follow 3
4 CVS HEALTH CORPORATION Condensed Consolidated Statements of Income Three Months Ended Six Months Ended June 30, June 30, In millions, except per share amounts (1) (1) Net revenues $ 45,685 $ 43,725 $ 90,199 $ 86,940 Cost of revenues 38,750 36,710 76,684 73,181 Gross profit 6,935 7,015 13,515 13,759 Operating expenses 4,818 4,658 9,605 9,217 Operating profit 2,117 2,357 3,910 4,542 Interest expense, net Loss on early extinguishment of debt Other expense Income before income tax provision 1,863 1,528 3,397 3,421 Income tax provision ,338 1,350 Income from continuing operations 1, ,059 2,071 Income (loss) from discontinued operations, net of tax 1 (8) Net income 1, ,051 2,071 Net income attributable to noncontrolling interest (1) (1) Net income attributable to CVS Health $ 1,098 $ 924 $ 2,050 $ 2,070 Basic earnings per share: Income from continuing operations attributable to CVS Health $ 1.07 $ 0.86 $ 2.00 $ 1.91 Loss from discontinued operations attributable to CVS Health $ $ $ (0.01) $ Net income attributable to CVS Health $ 1.07 $ 0.86 $ 1.99 $ 1.91 Weighted average shares outstanding 1,019 1,070 1,024 1,081 Diluted earnings per share: Income from continuing operations attributable to CVS Health $ 1.07 $ 0.86 $ 1.99 $ 1.90 Loss from discontinued operations attributable to CVS Health $ $ $ (0.01) $ Net income attributable to CVS Health $ 1.07 $ 0.86 $ 1.98 $ 1.90 Weighted average shares outstanding 1,024 1,075 1,029 1,087 Dividends declared per share $ 0.50 $ $ 1.00 $ 0.85 (1) Effective January 1, 2017, the Company adopted Accounting Standards Update ( ASU ) , Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which resulted in a retrospective reclassification of $7 million and $16 million of net benefit costs from operating expenses to other expense in the three and six months ended June 30, 2016, respectively. 4
5 CVS HEALTH CORPORATION Condensed Consolidated Balance Sheets June 30, December 31, In millions, except per share amounts Assets: Cash and cash equivalents $ 2,094 $ 3,371 Short-term investments Accounts receivable, net 12,274 12,164 Inventories 14,271 14,760 Other current assets Total current assets 29,404 31,042 Property and equipment, net 10,073 10,175 Goodwill 38,130 38,249 Intangible assets, net 13,354 13,511 Other assets 1,564 1,485 Total assets $ 92,525 $ 94,462 Liabilities: Accounts payable $ 7,874 $ 7,946 Claims and discounts payable 9,708 9,451 Accrued expenses 8,133 6,937 Short-term debt 1,100 1,874 Current portion of long-term debt Total current liabilities 26,857 26,250 Long-term debt 25,622 25,615 Deferred income taxes 4,210 4,214 Other long-term liabilities 1,689 1,549 Shareholders equity: CVS Health shareholders equity: Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding Common stock, par value $0.01: 3,200 shares authorized; 1,710 shares issued and 1,015 shares outstanding at June 30, 2017 and 1,705 shares issued and 1,061 shares outstanding at December 31, Treasury stock, at cost: 694 shares at June 30, 2017 and 643 shares at December 31, 2016 (37,414) (33,452) Shares held in trust: 1 share at June 30, 2017 and December 31, 2016 (31) (31) Capital surplus 31,871 31,618 Retained earnings 40,005 38,983 Accumulated other comprehensive income (loss) (306) (305) Total CVS Health shareholders equity 34,142 36,830 Noncontrolling interest 5 4 Total shareholders equity 34,147 36,834 Total liabilities and shareholders equity $ 92,525 $ 94,462 5
6 CVS HEALTH CORPORATION Condensed Consolidated Statements of Cash Flows Six Months Ended June 30, In millions (1) Cash flows from operating activities: Cash receipts from customers $ 88,343 $ 84,324 Cash paid for inventory and prescriptions dispensed by retail network pharmacies (73,748) (70,851) Cash paid to other suppliers and employees (7,000) (7,019) Interest received 10 9 Interest paid (539) (615) Income taxes paid (1,534) (1,762) Net cash provided by operating activities 5,532 4,086 Cash flows from investing activities: Purchases of property and equipment (888) (1,102) Proceeds from sale of property and equipment and other assets Acquisitions (net of cash acquired) and other investments (315) (168) Purchase of available-for-sale investments (39) Maturity of available-for-sale investments Net cash used in investing activities (1,174) (1,231) Cash flows from financing activities: Increase (decrease) in short-term debt (774) 745 Proceeds from issuance of long-term debt 3,455 Repayments of long-term debt (3,579) Purchase of noncontrolling interest in subsidiary (39) Dividends paid (1,028) (929) Proceeds from exercise of stock options Payments for taxes related to net share settlement of equity awards (60) (71) Repurchase of common stock (3,961) (3,960) Other (1) (4) Net cash used in financing activities (5,635) (4,189) Effect of exchange rate changes on cash and cash equivalents 2 Net decrease in cash and cash equivalents (1,277) (1,332) Cash and cash equivalents at the beginning of the period 3,371 2,459 Cash and cash equivalents at the end of the period $ 2,094 $ 1,127 Reconciliation of net income to net cash provided by operating activities: Net income $ 2,051 $ 2,071 Adjustments required to reconcile net income to net cash provided by operating activities: Depreciation and amortization 1,242 1,236 Goodwill impairment 135 Stock-based compensation Loss on early extinguishment of debt 542 Deferred income taxes and other noncash items Change in operating assets and liabilities, net of effects from acquisitions: Accounts receivable, net (114) (1,279) Inventories 492 (167) Other current assets (31) (170) Other assets (38) (53) Accounts payable and claims and discounts payable 180 1,164 Accrued expenses 1, Other long-term liabilities Net cash provided by operating activities $ 5,532 $ 4,086 (1) Effective January 1, 2017, the Company adopted ASU , Improvements to Employee Share-Based Payment Accounting, which resulted in a retrospective reclassification of $63 million of excess tax benefits from financing activities to operating activities which increased net cash provided by operating activities and increased cash used in financing activities for the six months ended June 30,
7 Non-GAAP Financial Measures The following provides reconciliations of certain non-gaap financial measures presented in this Form 8-K to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company uses the non- GAAP measures Adjusted EPS and Free Cash Flow to assess and analyze underlying business performance and trends. Management believes that providing these non-gaap measures enhances investors understanding of the Company s performance. The Company defines Adjusted Earnings per Share, or Adjusted EPS, as income from continuing operations excluding the impact of certain adjustments such as the amortization of intangible assets, acquisition-related transaction and integration costs, charges in connection with store rationalization, goodwill impairments, adjustments to legal reserves in connection with certain legal settlements, losses on early extinguishments of debt, and losses on settlements of defined benefit pension plans, divided by the Company s weighted average diluted shares outstanding. The Company believes that this measure enhances investors ability to compare the Company s past financial performance with its current performance. The Company defines Free Cash Flow as net cash provided by operating activities less net additions to property and equipment (i.e., additions to property and equipment plus proceeds from sale-leaseback transactions). Management uses this non-gaap financial measure for internal comparisons and finds it useful in assessing year-over-year cash flow performance. These non-gaap financial measures are provided as supplemental information to the financial measures presented in this press release that are calculated and presented in accordance with GAAP. Adjusted EPS should be considered in addition to, rather than as a substitute for, income before income tax provision as a measure of our performance. Free Cash Flow should be considered in addition to, rather than as a substitute for, net cash provided by operating activities as a measure of our liquidity. The Company s definitions of Adjusted EPS and Free Cash Flow may not be comparable to similarly titled measurements reported by other companies. 7
8 Adjusted Earnings Per Share The following is a reconciliation of income before income tax provision to Adjusted EPS: Three Months Ended Six Months Ended June 30, June 30, In millions, except per share amounts Income before income tax provision $ 1,863 $ 1,528 $ 3,397 $ 3,421 Non-GAAP adjustments: Amortization of intangible assets Acquisition-related integration costs (1) Charges in connection with store rationalization (2) Goodwill impairment (3) Charge related to a disputed 1999 legal settlement 3 Loss on early extinguishment of debt Adjusted income before income tax provision 2,217 2,348 4,165 4,504 Adjusted income tax provision ,586 1,770 Adjusted income from continuing operations 1,365 1,425 2,579 2,734 Net income attributable to noncontrolling interest (1) (1) Adjusted income allocable to participating securities (4) (6) (10) (13) Adjusted income from continuing operations attributable to CVS Health $ 1,361 $ 1,419 $ 2,568 $ 2,720 Weighted average diluted shares outstanding 1,024 1,075 1,029 1,087 Adjusted EPS $ 1.33 $ 1.32 $ 2.50 $ 2.50 (1) In 2017, the integration costs relate to the acquisition of Omnicare. In 2016, the integration costs relate to the acquisitions of Omnicare and the pharmacies and clinics of Target. (2) Primarily represents charges for noncancelable lease obligations associated with stores closed in connection with our enterprise streamlining initiative. (3) The goodwill impairment relates to the RxCrossroads reporting unit within the Retail/LTC Segment. 8
9 Free Cash Flow The following is a reconciliation of net cash provided by operating activities to Free Cash Flow: Six Months Ended June 30, In millions (1) Net cash provided by operating activities $ 5,532 $ 4,086 Subtract: Additions to property and equipment (888) (1,102) Free cash flow $ 4,644 $ 2,984 (1) Effective January 1, 2017, the Company adopted ASU , Improvements to Employee Share-Based Payment Accounting, which resulted in a retrospective reclassification of $63 million of excess tax benefits from financing activities to operating activities which increased net cash provided by operating activities for the six months ended June 30,
10 Supplemental Information The Company evaluates its Pharmacy Services and Retail/LTC segment performance based on net revenues, gross profit and operating profit before the effect of nonrecurring charges and gains and certain intersegment activities. The Company evaluates the performance of its Corporate Segment based on operating expenses before the effect of nonrecurring charges and gains and certain intersegment activities. The following is a reconciliation of the Company s segments to the accompanying condensed consolidated financial statements: Pharmacy Services Retail/LTC Corporate Intersegment Consolidated In millions Segment (1) Segment Segment Eliminations (2) Totals Three Months Ended June 30, 2017: Net revenues $ 32,325 $ 19,554 $ $ (6,194) $ 45,685 Gross profit (3) 1,469 5,675 (209) 6,935 Operating profit (loss) (4)(5) 1,135 1,411 (240) (189) 2,117 June 30, 2016: Net revenues 29,510 19,998 (5,783) 43,725 Gross profit (3) 1,367 5,837 (189) 7,015 Operating profit (loss) (5)(6) 1,039 1,711 (220) (173) 2,357 Six Months Ended June 30, 2017: Net revenues 63,548 38,895 (12,244) 90,199 Gross profit (3) 2,565 11,351 (401) 13,515 Operating profit (loss) (4)(5) 1,919 2,822 (466) (365) 3,910 June 30, 2016: Net revenues 58,275 40,110 (11,445) 86,940 Gross profit (3) 2,469 11,667 (377) 13,759 Operating profit (loss) (5)(6) 1,823 3,495 (432) (344) 4,542 (1) Net revenues of the Pharmacy Services Segment include approximately $2.7 billion and $2.6 billion of retail co-payments for the three months ended June 30, 2017 and 2016, respectively, as well as $5.8 billion and $5.6 billion of retail co-payments for the six months ended June 30, 2017 and 2016, respectively. (2) Intersegment eliminations relate to intersegment revenue generating activities that occur between the Pharmacy Services Segment and the Retail/LTC Segment. These occur in the following ways: when members of Pharmacy Services Segment clients ( members ) fill prescriptions at the Company s retail pharmacies to purchase covered products, when members enrolled in programs such as Maintenance Choice elect to pick up maintenance prescriptions at one of the Company s retail pharmacies instead of receiving them through the mail, or when members have prescriptions filled at the Company s long-term care pharmacies. When these occur, both the Pharmacy Services and Retail/LTC segments record the revenues, gross profit and operating profit on a standalone basis. (3) The Retail/LTC Segment gross profit for the three months ended June 30, 2017 and 2016 includes $5 million and $6 million, respectively, of acquisition-related integration costs. The Retail/LTC Segment gross profit for the six months ended June 30, 2017 and 2016 includes $5 million and $10 million, respectively, of acquisition-related integration costs. The integration costs in 2017 are related to the acquisition of Omnicare and the integration costs in 2016 are related to the acquisitions of Omnicare and the pharmacies and clinics of Target. (4) The Retail/LTC Segment operating profit for the three and six months ended June 30, 2017 includes a $135 million goodwill impairment charge. The Retail/LTC Segment operating profit for the three and six months ended June 30, 2017 also includes $6 million and $205 million, respectively, of charges associated with store closures. (5) The Retail/LTC Segment operating profit for the three months ended June 30, 2017 and 2016 includes $10 million and $81 million, respectively, of acquisition-related integration costs. The Retail/LTC Segment operating profit for the six months ended June 30, 2017 and 2016 includes $25 million and $142 million, respectively, of acquisition-related integration costs. The integration costs in 2017 are related to the acquisition of Omnicare and the integration costs in 2016 are related to the acquisitions of Omnicare and the pharmacies and clinics of Target. (6) Amounts revised to reflect the adoption of ASU , Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which increased consolidated operating profit by $7 million and $16 million in the three and six months ended June 30, 2016, respectively. 10
11 Supplemental Information Pharmacy Services Segment The following table summarizes the Pharmacy Services Segment s performance for the respective periods: Three Months Ended Six Months Ended June 30, June 30, In millions Net revenues $ 32,325 $ 29,510 $ 63,548 $ 58,275 Gross profit 1,469 1,367 2,565 2,469 Gross profit % of net revenues 4.5 % 4.6 % 4.0 % 4.2 % Operating expenses (1) Operating expenses % of net revenues 1.0 % 1.1 % 1.0 % 1.1 % Operating profit (1) 1,135 1,039 1,919 1,823 Operating profit % of net revenues 3.5 % 3.5 % 3.0 % 3.1 % Net revenues: Mail choice (2) $ 11,512 $ 10,646 $ 22,360 $ 20,796 Pharmacy network (3) 20,741 18,778 41,042 37,314 Other Pharmacy claims processed (90 Day = 3 prescriptions) (4)(5) : Total Mail choice (2) Pharmacy network (3) Generic dispensing rate (4)(5) : Total 87.2 % 85.9 % 87.1 % 85.7 % Mail choice (2) 83.1 % 81.2 % 82.9 % 80.8 % Pharmacy network (3) 87.9 % 86.8 % 87.8 % 86.6 % Mail choice penetration rate (4)(5) 14.9 % 15.5 % 14.7 % 15.3 % (1) Amounts revised to reflect the adoption of ASU , Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which decreased operating expenses and increased operating profit by $1 million for the three months ended June 30, For the six months ended June 30, 2016, the adoption of ASU decreased operating expenses and increased operating profit by $3 million. (2) Mail choice is defined as claims filled at a Pharmacy Services mail facility, which includes specialty mail claims inclusive of Specialty Connect claims picked up at retail, as well as prescriptions filled at our retail pharmacies under the Maintenance Choice program. (3) Pharmacy network net revenues, claims processed and generic dispensing rates do not include Maintenance Choice activity, which is included within the mail choice category. Pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including our retail pharmacies and long-term care pharmacies, but excluding Maintenance Choice activity. (4) Includes the adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription. (5) The pharmacy claims processed, the generic dispensing rate and the mail choice penetration rate for the three and six months ended June 30, 2016 has been revised to reflect 90-day prescriptions to the equivalent of three 30-day prescriptions. 11
12 Supplemental Information Retail/LTC Segment The following table summarizes the Retail/LTC Segment s performance for the respective periods: Three Months Ended Six Months Ended June 30, June 30, In millions Net revenues $ 19,554 $ 19,998 $ 38,895 $ 40,110 Gross profit (1)(2) 5,675 5,837 11,351 11,667 Gross profit % of net revenues 29.0 % 29.2 % 29.2 % 29.1 % Operating expenses (1)(2)(3)(4) 4,264 4,126 8,529 8,172 Operating expenses % of net revenues 21.8 % 20.6 % 21.9 % 20.4 % Operating profit (4) 1,411 1,711 2,822 3,495 Operating profit % of net revenues 7.2 % 8.6 % 7.3 % 8.7 % Prescriptions filled (90 Day = 3 prescriptions) (5) Net revenue increase (decrease): Total (2.2)% 16.0 % (3.0)% 17.3 % Pharmacy (2.5)% 21.2 % (3.1)% 22.4 % Front Store (1.3)% (0.6)% (2.6)% 1.0 % Total prescription volume (90 Day = 3 prescriptions) (5) 0.2 % 23.2 % (0.2)% 24.8 % Same store sales increase (decrease) (6) : Total (2.6)% 2.1 % (3.7)% 3.1 % Pharmacy (2.8)% 3.9 % (3.7)% 4.7 % Front Store (2.1)% (2.5)% (3.5)% (0.9)% Prescription volume (90 Day = 3 prescriptions) (5) 0.0 % 3.5 % (0.7)% 4.7 % Generic dispensing rates 87.6 % 86.1 % 87.6 % 85.9 % Pharmacy % of net revenues 74.6 % 74.8 % 74.6 % 74.7 % (1) Gross profit and operating expenses for the three months ended June 30, 2017 each include $5 million of acquisition-related integration costs. Gross profit and operating expenses for the six months ended June 30, 2017 include $5 million and $20 million, respectively, of acquisitionrelated integration costs. The integration costs are related to the acquisition of Omnicare. (2) Gross profit and operating expenses for the three months ended June 30, 2016 include $6 million and $75 million, respectively, of acquisitionrelated integration costs. Gross profit and operating expenses for the six months ended June 30, 2016 includes $10 million and $132 million, respectively, of acquisition-related integration costs. The integration costs are related to the acquisitions of Omnicare and the pharmacies and clinics of Target. (3) Operating expenses for the three and six months ended June 30, 2017 include a $135 million goodwill impairment charge. Operating expenses for the three and six months ended June 30, 2017 also includes $6 million and $205 million, respectively, of charges associated with store closures. (4) Amounts revised to reflect the adoption of ASU , Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which decreased operating expenses and increased operating profit by $6 million for the three months ended June 30, For the six months ended June 30, 2016, the adoption of ASU decreased operating expenses and increased operating profit by $13 million. (5) Includes the adjustment to convert 90-day non-specialty prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription. (6) Same store sales and prescriptions exclude revenues from MinuteClinic, and revenue and prescriptions from stores in Brazil, LTC operations and from commercialization services. 12
13 Adjusted Earnings Per Share Guidance The following reconciliation of estimated income before income tax provision to estimated adjusted earnings per share contains forward-looking information. All forward-looking information involves risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking information for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled Cautionary Statement Concerning Forward-Looking Statements in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. See also previous discussion at Non-GAAP Financial Measures for more information on how we calculate Adjusted EPS. Year Ending In millions, except per share amounts December 31, 2017 Income before income tax provision $ 8,332 $ 8,498 Non-GAAP adjustments: Amortization of intangible assets Acquisition-related integration costs Charges in connection with store rationalization Goodwill impairment Loss on settlement of defined benefit pension plan Adjusted income before income tax provision 9,772 9,938 Adjusted income tax provision 3,782 3,850 Adjusted income from continuing operations 5,990 6,088 Net income attributable to noncontrolling interest (1) (1) Adjusted income allocable to participating securities (22) (22) Adjusted income from continuing operations attributable to CVS Health $ 5,967 $ 6,065 Weighted average diluted shares outstanding 1,023 1,023 Adjusted earnings per share $ 5.83 $ 5.93 Three Months Ending In millions, except per share amounts September 30, 2017 Income before income tax provision $ 2,004 $ 2,077 Non-GAAP adjustments: Amortization of intangible assets Acquisition-related integration costs Charge in connection with store rationalization Loss on settlement of defined benefit pension plan Adjusted income before income tax provision 2,454 2,527 Adjusted income tax provision Adjusted income from continuing operations 1,498 1,539 Net income attributable to noncontrolling interest Adjusted income allocable to participating securities (3) (3) Adjusted income from continuing operations attributable to CVS Health $ 1,495 $ 1,536 Weighted average diluted shares outstanding 1,020 1,021 Adjusted earnings per share $ 1.47 $
14 Free Cash Flow Guidance The following reconciliation of net cash provided by operating activities to free cash flow contains forward-looking information. All forward-looking information involves risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking information for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled Cautionary Statement Concerning Forward-Looking Statements in our most recently filed Annual Report on Form 10- K and Quarterly Report on Form 10-Q. See also previous discussion at Non-GAAP Financial Measures for more information on how we calculate Free Cash Flow. Year Ending In millions December 31, 2017 Net cash provided by operating activities $ 7,700 $ 8,600 Subtract: Additions to property and equipment (2,000) (2,400) Add: Proceeds from sale-leaseback transactions Free cash flow $ 6,000 $ 6,400 14
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
Investor Nancy Christal Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (914) (401)
Investor Nancy Christal Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (914) 722-4704 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
(401) (212) FOR IMMEDIATE RELEASE CVS HEALTH REPORTS FOURTH QUARTER AND FULL YEAR RESULTS AND PROVIDES 2019 FULL YEAR GUIDANCE
Investor Mike McGuire Media T.J. Crawford Contact: Senior Vice President Contact: Vice President Investor Relations External Affairs (401) 770-4050 (212) 457-0583 FOR IMMEDIATE RELEASE CVS HEALTH REPORTS
1 sur 10 03/02/ :56
1 sur 10 03/02/2011 13:56 Print Page Close Window Press Release
CVS Caremark Reports Results for First Quarter First Quarter Year-Over-Year Highlights:
CVS Caremark Reports Results for First Quarter 2009 First Quarter Year-Over-Year Highlights: Adjusted EPS from continuing operations of $0.55 [excluding amortization] GAAP diluted EPS from continuing operations
Reconciliation of Non-GAAP Items Required by SEC Rules
2016 ACTUAL RESULTS CVS Health is providing non-gaap information that excludes certain items because of the nature of these items and the impact they have on the analysis of underlying business performance
Reconciliation of Non-GAAP Items
2016 GUIDANCE CVS Health is providing non-gaap information that excludes certain items because of the nature of these items and the impact they have on the analysis of underlying business performance and
CVS CAREMARK REPORTS RECORD SECOND QUARTER REVENUES, OPERATING PROFIT, AND EARNINGS
Investor Contact: Nancy Christal Media Contact: Eileen Howard Dunn Senior Vice President Senior Vice President Investor Relations Corporate Communications & (914) 722-4704 Community Relations (401) 770-4561
Second Quarter 2017 Earnings Conference Call
Second Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer August 8, 2017 Forward-looking Statements This
Fourth Quarter 2016 Earnings Conference Call
Fourth Quarter 2016 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 9, 2017 Revised 2/9 Forward-looking
2018 Guidance Conference Call
2018 Guidance Conference Call Dave Denton Executive Vice President & Chief Financial Officer January 4, 2018 Important Information for Investors and Shareholders No Offer or Solicitation Today's presentation
Fourth Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 8, 2018 Important Information No Offer
Fourth Quarter 2018 Earnings Conference Call Larry Merlo President & Chief Executive Officer Eva Boratto Executive Vice President & Chief Financial Officer February 20, 2019 Cautionary Statement Regarding
Earnings. Larry Merlo. President & Chief Executive Officer. Executive Vice President & Chief Financial Officer. November 4, 2014
Third dquate Quarter Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer November 4, 2014 Forward-looking Statements
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended
Earnings Conference Call
First Quarter 2015 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer May 1, 2015 Forward-looking Statements During
Third Quarter 2017 Earnings Conference Call
Third Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer November 6, 2017 Forward-looking Statements This
Key results. "We have good momentum in the business with solid sales growth across Walmart U.S., Sam's Club and
Walmart U.S. Q4 comps grew 2.6% and Walmart U.S. ecommerce sales grew 23%, Walmart U.S. full year comps grew 2.% and Walmart U.S. ecommerce sales grew 44%, Fiscal year GAAP EPS of 3.28; Adjusted EPS2 of
DANA HOLDING CORPORATION Quarterly Financial Information and Reconciliations of Non-GAAP Financial Measures
Quarterly Financial Information and Reconciliations of Non-GAAP Financial Measures Non-GAAP Financial Measures Adjusted EBITDA is a non-gaap financial measure which we have defined as earnings from continuing
Walgreen Co. Reports Fiscal 2014 Second Quarter Results
March 25, 2014 Walgreen Co. Reports Fiscal 2014 Second Quarter Results Company reports adjusted second quarter earnings per diluted share of 91 cents, compared with adjusted earnings per diluted share
GILAT SATELLITE NETWORKS LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS U.S. dollars in thousands (except share and per share data)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (except share and per share data) 2016 2015 2016 2015 Audited Revenues $ 279,551 $ 197,543 $ 80,345 $ 67,682 Cost of revenues 204,061 143,318 56,147 47,181
Diplomat Announces 4th Quarter and 2017 Year End Financial Results; Provides 2018 Guidance
NEWS RELEASE Diplomat Announces 4th Quarter and 2017 Year End Financial Results; Provides 2018 Guidance 2/26/2018 4th Quarter Revenue of $1,155 Million, Net Income Attributable to Diplomat of $6.5 Million,
LABCORP ANNOUNCES 2018 SECOND QUARTER RESULTS AND UPDATES 2018 GUIDANCE
FOR IMMEDIATE RELEASE Contact: Scott Frommer (investors) 336-436-5076 Investor@labcorp.com Pattie Kushner (media) 336-436-8263 Media@labcorp.com LABCORP ANNOUNCES 2018 SECOND QUARTER RESULTS AND UPDATES
Cardinal Health Reports Second-quarter Results for Fiscal Year 2018
FOR IMMEDIATE RELEASE Media: Ellen Barry Investors: Lisa Capodici (614) 553-3858 (614) 757-5035 ellen.barry@cardinalhealth.com lisa.capodici@cardinalhealth.com Cardinal Health Reports Second-quarter Results
DIPLOMAT PHARMACY, INC.
DIPLOMAT PHARMACY, INC. FORM 8-K (Current report filing) Filed 05/11/15 for the Period Ending 05/11/15 Address 4100 S. SAGINAW ST. FLINT, MI 48507 Telephone 888-720-4450 CIK 0001610092 Symbol DPLO SIC
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
Key results. Doug McMillon President and CEO, Walmart. Revenue (constant currency)2. Operating income (constant currency)2. Returns to Shareholders
Walmart U.S. Q3 comps1 grew 2.7% and Walmart U.S. ecommerce sales grew 50%, Company reports Q3 FY18 GAAP EPS of 0.58; Adjusted EPS2 of 1.00, The company now expects full-year GAAP EPS of 3.84 to 3.92,
Walgreen Co. Reports Fiscal 2013 First Quarter Results
December 21, 2012 Walgreen Co. Reports Fiscal 2013 First Quarter Results Company reports adjusted first quarter earnings per diluted share of 58 cents, compared with adjusted earnings per diluted share
CVS Health Corporation Supplemental Financial Information Preliminary and Unaudited. Fourth Quarter 2014 Earnings Release February 10, 2015
CVS Health Corporation Supplemental Financial Information Preliminary and Unaudited Earnings Release February 10, 2015 The information in this report includes non-gaap financial measures related to our
WestRock Reports Solid Results in Fiscal 2017 First Quarter
WestRock Reports Solid Results in Fiscal 2017 First Quarter NORCROSS, Ga., January 24, 2017 (GLOBE NEWSWIRE) -- WestRock Company (WestRock) (NYSE:WRK), a leading provider of differentiated paper and packaging
market share gains in key categories, according to Nielsen and The NPD Group. equipped with the tools to serve customers
Walmart U.S. Q3 comp sales grew 3.4% and Walmart U.S. ecommerce sales grew 43%, Q3 GAAP EPS of 0.58; Adjusted EPS2 of.08, Walmart now expects FY'9 GAAP EPS of 2.26 to 2.36, Walmart raises guidance for
Colfax Reports Third Quarter 2018 Results
Colfax Reports Third Quarter 2018 Results Reported net income from continuing operations per diluted share of $0.29 versus $0.35 in the prior year quarter, and achieved adjusted net income per share of
Colfax Reports First Quarter 2018 Results
Colfax Reports First Quarter 2018 Results Achieved net income per diluted share of $0.22 from continuing operations, and adjusted net income per share of $0.48 versus $0.39 in the prior year Grew sales
McKESSON REPORTS FISCAL 2015 SECOND-QUARTER RESULTS
McKESSON REPORTS FISCAL 2015 SECOND-QUARTER RESULTS Revenues of $44.8 billion for the second quarter, up 36%. Second-quarter GAAP earnings per diluted share from continuing operations of $2.05, up 13%.
Company raises fiscal year 2016 non-gaap diluted EPS guidance range from $1.85 to $2.00, to $1.90 to $2.00
BOB EVANS REPORTS FISCAL 2016 THIRD-QUARTER RESULTS Q3 2016 net sales total $346.5 million. GAAP and non-gaap net income (1) of $0.62 per diluted share, represents an increase of 148 percent and 3 percent,
Jack in the Box Inc. Reports Third Quarter FY 2015 Earnings; Updates Guidance for FY 2015; Declares Quarterly Cash Dividend
Investor Contact: Carol DiRaimo, (858) 571-2407 FOR IMMEDIATE RELEASE Media Contact: Brian Luscomb, (858) 571-2291 Reports Third Quarter FY Earnings; Updates Guidance for FY ; Declares Quarterly Cash Dividend
Colfax Reports Third Quarter Results October 25, ANNAPOLIS JUNCTION, MD, Oct. 25, (GLOBE NEWSWIRE) -- Reported net income from continuing operations per diluted share of $0.29 versus $0.35 in the prior
Jack in the Box Inc. Reports First Quarter FY 2013 Earnings; Updates Guidance for FY 2013
Investor Contact: Carol DiRaimo, (858) 571-2407 FOR IMMEDIATE RELEASE Media Contact: Brian Luscomb, (858) 571-2291 Reports First Quarter FY 2013 Earnings; Updates Guidance for FY 2013 SAN DIEGO, February
Express Scripts Announces 2017 Fourth Quarter and Full Year Results
Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 investor.relations@express-scripts.com Express Scripts Announces 2017 Fourth Quarter and Full Year
CORNING INCORPORATED AND SUBSIDIARY COMPANIES CONSOLIDATED STATEMENTS OF INCOME (Unaudited; in millions, except per share amounts)
CONSOLIDATED STATEMENTS OF INCOME (Unaudited; in millions, except per share amounts) 2012 2011 Net sales $ 1,920 $ 1,923 Cost of sales 1,106 1,049 Gross margin 814 874 Operating expenses: Selling, general
Walmart reports Q3 FY17 EPS of $0.98, The company now expects full-year GAAP EPS of $4.34 to $4.49, Adjusted full-year EPS1 of $4.20 to $4.
Walmart reports Q3 FY7 EPS of 0.98, The company now expects full-year GAAP EPS of 4.34 to 4.49, Adjusted full-year EPS of 4.0 to 4.35 Diluted EPS was 0.98. Currency negatively impacted EPS by approximately
Macy s, Inc. Reports Third Quarter 2018 Earnings
November 14, 2018 Macy s, Inc. Reports Third Quarter 2018 Earnings Comparable sales growth of 3.1% on an owned basis; 3.3% on an owned plus licensed basis Higher sales and earnings driven by strong digital,
Jack in the Box Inc. Reports Second Quarter FY 2015 Earnings; Updates Guidance for FY 2015; Raises Quarterly Cash Dividend by 50%
Investor Contact: Carol DiRaimo, (858) 571-2407 FOR IMMEDIATE RELEASE Media Contact: Brian Luscomb, (858) 571-2291 Reports Second Quarter FY Earnings; Updates Guidance for FY ; Raises Quarterly Cash Dividend
WELLCARE HEALTH PLANS, INC. (Exact name of registrant as specified in its charter)
Section 1: 8-K (8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report
3 rd Quarter 2018 Earnings Release Conference Call
3 rd Quarter 2018 Earnings Release Conference Call October 31, 2018 1 2018 Belden Inc. belden.com @beldeninc Safe Harbor Statement Our commentary and responses to your questions may contain forward-looking
news FOR IMMEDIATE RELEASE
news FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Ed Fishbough 615-344-2688 615-344-2810 HCA Reports First Quarter 2018 Results Nashville, Tenn., May 1, 2018 HCA Healthcare, Inc.
Colfax Reports Fourth Quarter 2018 Results
Colfax Reports Fourth Quarter Results Reported net income (loss) from continuing operations per diluted share of $0.36 versus $(1.53) in the prior year quarter; achieved adjusted net income per share of
Walgreens Boots Alliance Reports Fiscal 2019 First Quarter Results Delivers Double Digit Percentage Growth in Earnings Per Share (EPS)
Walgreens Boots Alliance Reports Fiscal 2019 First Quarter Results Delivers Double Digit Percentage Growth in Earnings Per Share (EPS) First quarter highlights, year-over-year Sales increased 9.9 percent
4 th Quarter 2018 Earnings Release Conference Call
4 th Quarter 2018 Earnings Release Conference Call February 20, 2019 1 2019 Belden Inc. belden.com @beldeninc Safe Harbor Statement Our commentary and responses to your questions may contain forward-looking
CIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016 o o o
UNISYS CORPORATION CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (Millions, except per share data)
CONSOLIDATED STATEMENTS OF INCOME (Millions, except per share data) Three Months Nine Months Ended September 30 Ended September 30 2012 2011 2012 2011 Revenue Services $748.0 $876.3 $2,386.7 $2,519.3 Technology
Investor Contact: Carol DiRaimo, (858) 571-2407 FOR IMMEDIATE RELEASE Media Contact: Brian Luscomb, (858) 571-2291 Jack in the Box Inc. Reports First Quarter FY 2015 Earnings; Updates Guidance for FY 2015
McKESSON REPORTS FISCAL 2012 SECOND-QUARTER RESULTS Revenues of $30.2 billion for the second quarter, up 10%. Second-quarter GAAP earnings per diluted share of $1.18. Second-quarter per diluted share of
Reported EPS from continuing operations for the fourth quarter included tax benefits of $243 million, or approximately $0.07 cents per share.
For Immediate Release Media Relations Contact Greg Rossiter 800-331-0085 Investor Relations Contact Carol Schumacher 479-277-1498 Pre-recorded conference call 800-778-6902 (U.S. and Canada) 585-219-6420
McKESSON REPORTS FISCAL 2013 SECOND-QUARTER RESULTS Revenues of $29.9 billion for the second quarter, down 1%. Second-quarter GAAP earnings per diluted share of $1.67, up 42%. Second-quarter per diluted
Jack in the Box Inc. Reports Second Quarter FY 2014 Earnings; Updates Guidance for FY 2014
Investor Contact: Carol DiRaimo, (858) 571-2407 FOR IMMEDIATE RELEASE Media Contact: Brian Luscomb, (858) 571-2291 Reports Second Quarter FY Earnings; Updates Guidance for FY SAN DIEGO, May 14, (NASDAQ:
ServiceNow, Inc. Condensed Consolidated Statements of Operations (in thousands, except share and per share data) (Unaudited)
Condensed Consolidated Statements of Operations (in thousands, except share and per share data) September 30, 2016 September 30, 2015 September 30, 2016 September 30, 2015 Revenues: Subscription $ 318,934
WALGREEN CO FORM 8-K. (Current report filing) Filed 12/22/08 for the Period Ending 12/22/08
WALGREEN CO FORM 8-K (Current report filing) Filed 12/22/08 for the Period Ending 12/22/08 Address 200 WILMOT RD DEERFIELD, IL 60015 Telephone 8479402500 CIK 0000104207 Symbol WAG SIC Code 5912 - Drug
McKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS
McKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS Revenues of $47 billion for the third quarter, up 37%. Third-quarter GAAP earnings per diluted share from continuing operations of $2.01, up 187%. Third-quarter
ALLEGION REPORTS SECOND-QUARTER 2018 FINANCIAL RESULTS
ALLEGION REPORTS SECOND-QUARTER 2018 FINANCIAL RESULTS Second-quarter 2018 net earnings per share (EPS) of $1.19, compared with 2017 EPS of $1.10; usted 2018 EPS of $1.25, up 12.6 percent compared with
Total Premium Revenue (GAAP) ($ millions) $4,390.9 $3,578.8 Adjusted Premium Revenue (1) ($ millions) $4,361.4 $3,483.3
WELLCARE REPORTS THIRD QUARTER 2017 RESULTS COMPANY INCREASES FULL-YEAR 2017 GUIDANCE TAMPA, Fla. (Oct. 31, 2017) WellCare Health Plans, Inc. (NYSE: WCG) ( WellCare ) today reported results for the quarter
R. R. DONNELLEY & SONS COMPANY (Exact name of Registrant as Specified in Its Charter)
ALLEGION REPORTS FIRST-QUARTER 2018 FINANCIAL RESULTS
ALLEGION REPORTS FIRST-QUARTER 2018 FINANCIAL RESULTS First-quarter 2018 net earnings per share (EPS) of $0.75, compared with 2017 EPS of $0.71; usted 2018 EPS of $0.80, up 9.6 percent compared with 2017
Page 1 of 6 Print Page Close Window Press Release Henry Schein Reports Record Fourth Quarter And Annual Results Q4 EPS up 9.1% to $1.56 Affirms 2015 financial guidance range MELVILLE, N.Y., Feb. 11, 2015
Investor Contact: Carol DiRaimo, (858) 571-2407 FOR IMMEDIATE RELEASE Media Contact: Brian Luscomb, (858) 571-2291 Jack in the Box Inc. Reports Third Quarter FY Earnings; Updates Guidance for FY ; Declares
Pentair Reports Fourth Quarter and Full Year 2013 Results
News Release Pentair Reports Fourth and Full Year 2013 Results Fourth quarter sales of $1.9 billion. Fourth quarter adjusted EPS grew 62 percent to $0.86. Full year adjusted free cash flow exceeded 110
Fiscal Capital Allocation Strategy
THE HOME DEPOT ANNOUNCES FOURTH QUARTER AND FISCAL RESULTS; ANNOUNCES $17 BILLION SHARE REPURCHASE AUTHORIZATION; INCREASES QUARTERLY DIVIDEND BY 34 PERCENT AND PROVIDES FISCAL YEAR GUIDANCE ATLANTA, February
Walgreens Boots Alliance Reports Fiscal 2018 Third Quarter Results
Alliance Reports Fiscal 2018 Third Quarter Results June 28, 2018 Third quarter highlights GAAP diluted net earnings per share increased 26.2 percent from the year-ago quarter, to $1.35; Adjusted diluted
Walgreens Boots Alliance Reports Fourth Quarter and Fiscal 2017 Results
October 25, 2017 Boots Alliance Reports Fourth Quarter and Fiscal 2017 Results Fourth quarter highlights GAAP diluted net earnings per share were $0.76, down 20.0 percent from the year-ago quarter due
Best Buy Reports Third Quarter Results
Best Buy Reports Third Quarter Results Enterprise Comparable Sales Increased 4.4% Diluted EPS of $0.78 Increased 30% Raising FY18 Financial Outlook MINNEAPOLIS, November 16, -- Best Buy Co., Inc. (NYSE:
Staples, Inc. Announces First Quarter 2017 Performance
Media Contact: Bill Durling 508-253-2882 Investor Contact: Chris Powers/Scott Tilghman 508-253-4632/1487 Staples, Inc. Announces First Quarter 2017 Performance FRAMINGHAM, Mass., May 16, 2017 Staples,
CONSOLIDATED STATEMENTS OF INCOME (Unaudited; in millions, except per share amounts) Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Net sales $ 3,008 $ 2,607 $ 8,255
GRAINGER REPORTS RESULTS FOR THE 2018 THIRD QUARTER Revenue grows 7.4%; 8.2% excluding foreign exchange and impact of hurricanes
News Release GRAINGER REPORTS RESULTS FOR THE 2018 THIRD QUARTER Revenue grows 7.4%; 8.2% excluding foreign exchange and impact of hurricanes Quarterly Summary Reported operating earnings of $189 million,
Discussion of Results (Percentage changes compare Q3 12 to Q3 11, unless otherwise noted.)
Tenet Reports Third Quarter Adjusted EBITDA Growth of 40% to $269 Million 5.8% Growth in Net Operating Revenues 1.4% Increase in Adjusted Admissions 6.3% Growth in Outpatient Surgeries 3.7% Increase in
Express Scripts Announces 2017 Third Quarter Results
Contact: Ben Bier, Vice President, Investor Relations (314) 810-3115 investor.relations@express-scripts.com Express Scripts Announces 2017 Third Quarter Results ST. LOUIS, October 24, 2017 Express Scripts
KOHL'S CORPORATION REPORTS SECOND QUARTER EARNINGS PER SHARE OF $ AN INCREASE OF 27.8 PERCENT
FOR IMMEDIATE RELEASE August 10, KOHL'S CORPORATION REPORTS SECOND QUARTER EARNINGS PER SHARE OF $0.69 - AN INCREASE OF 27.8 PERCENT MENOMONEE FALLS, Wis., August 10, Kohl's Corporation today reported
Tenet Reports Fourth Quarter Adjusted EBITDA of $336 Million, an Increase of 16.7% 7.3% Growth in Net Operating Revenues 2.9% Increase in Adjusted Admissions 7.5% Growth in Surgeries DALLAS February 26,
Gardner Denver Reports Strong Second Quarter 2018 Results and Raises Full Year 2018 Adjusted EBITDA Midpoint Guidance
August 1, 2018 Gardner Denver Reports Strong Second Quarter 2018 Results and Raises Full Year 2018 Adjusted EBITDA Midpoint Guidance Revenues of $668.2 million increased 15% over the prior year, supported
UNITED TECHNOLOGIES REPORTS SECOND QUARTER 2018 RESULTS RAISES 2018 OUTLOOK
UNITED TECHNOLOGIES REPORTS SECOND QUARTER 2018 RESULTS RAISES 2018 OUTLOOK Organic sales growth momentum continues in Q2; Robust cash generation in the quarter; Raises sales and adjusted EPS outlook for
VISHAY INTERTECHNOLOGY, INC. Summary of Operations (Unaudited - In thousands, except per share amounts)
Summary of Operations (Unaudited - In thousands, except per share amounts) Fiscal quarters ended June 30, 2018 March 31, 2018 July 1, 2017* Net revenues $ 761,030 $ 716,795 $ 643,164 Costs of products
McKESSON REPORTS FISCAL 2017 SECOND-QUARTER RESULTS AND REVISED FISCAL 2017 OUTLOOK
McKESSON REPORTS FISCAL 2017 SECOND-QUARTER RESULTS AND REVISED FISCAL 2017 OUTLOOK Revenues of $50.0 billion for the second quarter, up 2% year-over-year. Second-quarter GAAP earnings per diluted share
Humana Reports Third Quarter 2017 Financial Results
n e w s r e l e a s e Humana Inc. 500 West Main Street P.O. Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Amy Smith Humana Investor Relations (502) 580 2811 e mail:
The Home Depot Announces First Quarter Results; Reaffirms Fiscal Year 2018 Guidance
The Home Depot Announces First Quarter Results; Reaffirms Fiscal Year 2018 Guidance ATLANTA, May 15, 2018 -- The Home Depot, the world's largest home improvement retailer, today reported sales of $24.9
Walmart U.S. Q1 comps1,2 grew 2.1% and Walmart U.S. ecommerce sales grew 33%, Company reports Q1 GAAP EPS of $0.72; Adjusted EPS2 of $1.
Walmart U.S. Q comps, grew.% and Walmart U.S. ecommerce sales grew 33%, Company reports Q GAAP EPS of 0.7; Adjusted EPS of.4 Total revenue was.7 billion, an increase of 5. billion, or 4.4%. Excluding currency,
Snap-on Announces Third Quarter 2018 Results
Release: IMMEDIATE Snap-on Announces Third Quarter 2018 Results Q3 2018 reported diluted EPS of $2.85, including $0.03 charge related to U.S. tax legislation, up 24.5% from Q3 2017; Q3 2018 adjusted diluted
Best Buy Reports Better-than-Expected Second Quarter Results
Best Buy Reports Better-than-Expected Second Quarter Results Enterprise Comparable Sales Increased 6.2% GAAP Diluted EPS Increased 28% to $0.86 Non-GAAP Diluted EPS Increased 32% to $0.91 Raising FY19
Colfax Reports Fourth Quarter 2017 Results Reported loss from continuing operations of $1.53 per diluted share and adjusted earnings per share of $0.45 Fabrication Technology achieved 7% organic sales
Walmart reports Q3 EPS of $1.14, updates full year guidance; Aggressive holiday plans to drive sales
For Immediate Release Media Relations Contact Randy Hargrove 800-33-0085 Investor Relations Contact Carol Schumacher 479-277-498 Pre-recorded management call 877-523-562 (U.S. and Canada) 20-689-8483 (other
FOR IMMEDIATE RELEASE. Investor Contact: Carol DiRaimo, (858) Media Contact: Brian Luscomb, (858)
Investor Contact: Carol DiRaimo, (858) 571-2407 FOR IMMEDIATE RELEASE Media Contact: Brian Luscomb, (858) 571-2291 Jack in the Box Inc. Reports Second Quarter FY Earnings; Updates Guidance for FY ; Declares
more On Aug. 17, 2016, Target provided third quarter 2016 GAAP EPS from continuing operations and Adjusted EPS guidance of $0.75 to $0.95.
FOR IMMEDIATE RELEASE Contacts: John Hulbert, Investors, (612) 761-6627 Erin Conroy, Media, (612) 761-5928 Target Media Hotline, (612) 696-3400 Target Reports Third Quarter Earnings GAAP EPS from continuing
Summary of Operations (Unaudited - In thousands, except per share amounts) December 31, 2018 December 31, 2017* Net revenues $ 3,034,689 $ 2,599,368 Costs of products sold 2,146,165 1,896,259 Gross profit
National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2017 Financial Results
National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2017 Financial Results Duluth, Ga. -- Mar. 8, 2018 -- National Vision Holdings, Inc. (NASDAQ: EYE) ( National Vision or the Company ) today


text:
Q: Lost hard drive space. It's disappeared I tried to bootcamp my Mac. Ran into some issues which left me with two partitions, my main partion and the extra one create for bootcamp installation. Tried to merge it using the bootcamp programme, but didn't give me the option. Went to disk utility and tried to merge them through the GUI, wasn't working. The minus button was not highlighted. Then went into terminal and tried to delete the partion as free space and then merge to one partion. This worked in part, the second partion is deleted but I can not restore the main partion back to it full volume size. I've lost space, where I had over 1TB free I know have only 750GB. I have no idea how to get it back. Any help would be appreciated.

A: You can not recover 300 GB of free space because the small 104.9 MB EFI partition is between the APFS container and this free space. The command below will remove the EFI partition and add the 104.9 MB to the 300 GB of free space that already exists.
diskutil eraseVolume free none disk1s3

The next command will expand the APFS container to occupy the free space.
diskutil apfs resizeContainer disk1s2 0

If you still feel the "Macintosh HD" volume (disk2s1) is occupying to much space, you may want to ask a new question to address this problem.

redpajama_set_name: RedPajamaStackExchange